Evidence map›Paper›PMID 37259860›Full record

ReviewCirculation. Cardiovascular interventions2023

Coronary Microvascular Disease in Contemporary Clinical Practice.

Nathaniel R Smilowitz, Olga Toleva, Alaide Chieffo, Divaka Perera, Colin Berry

Open access · greenAbstract readReview
In one paragraph

Review in Circulation. Cardiovascular interventions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Interaction between coronary lesion complexity and coronary microvascular dysfunction in the prognosis of NSTEMI patients.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  3. Chronic Inflammation and Coronary Microvascular Dysfunction.Reviews in cardiovascular medicine · 2026
    Review
  4. Review
  5. Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Nathaniel R SmilowitzDivision of Cardiology, Department of Medicine, NYU Langone Health, NY (N.R.S.).ORCID 0000-0002-6823-2815
Olga TolevaEmory University, Atlanta, GA (O.T.).
Alaide ChieffoInterventional Cardiology Unit, San Raffaele Hospital, Milan, Italy (A.C.).ORCID 0000-0002-3505-9112
Divaka PereraSchool of Cardiovascular and Metabolic Medicine and Sciences, King's College London, UK (D.P.).ORCID 0000-0001-6362-1291
Colin BerryBritish Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Scotland, UK (C.B.).ORCID 0000-0002-4547-8636
Emory University · USGolden Jubilee National Hospital · GBSan Raffaele University of Rome · ITSt Thomas' Hospital · GBVA NY Harbor Healthcare System · US

Funding

New Approaches to Mitigate Left Ventricular Injury with VA-ECMO in Acute Myocardial InfarctionR01HL159089 · NHLBI · TUFTS MEDICAL CENTER · PI KAPUR, NAVIN KUMAR · 2021 to 2024
$3.4M
Mechanisms of Coronary Microvascular DiseaseK23HL150315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMILOWITZ, NATHANIEL ROSSO · 2020 to 2024
$948k
Medical Research Council MR/S018905/1NHLBI NIH HHS K23 HL150315NHLBI NIH HHS R01 HL159089
6 · The paper itself

Abstract

Coronary microvascular disease (CMD) causes myocardial ischemia in a variety of clinical scenarios. Clinical practice guidelines support routine testing for CMD in patients with ischemia with nonobstructive coronary artery disease. Invasive testing to identify CMD requires Doppler or thermodilution measures of flow to determine the coronary flow reserve and measures of microvascular resistance. Acetylcholine coronary reactivity testing identifies concomitant endothelial dysfunction, microvascular spasm, or epicardial coronary spasm. Comprehensive testing may improve symptoms, quality of life, and patient satisfaction by establishing a diagnosis and guiding-targeted medical therapy and lifestyle measures. Beyond ischemia with nonobstructive coronary artery disease, testing for CMD may play a role in patients with acute myocardial infarction, angina following coronary revascularization, heart failure with preserved ejection fraction, Takotsubo syndrome, and after heart transplantation. Additional education and provider awareness of CMD and its role in cardiovascular disease is needed to improve patient-centered outcomes of ischemic heart disease.

Indexed as

Coronary Artery DiseaseMicrovascular AnginaMyocardial IschemiaCoronary AngiographyCoronary CirculationCoronary VesselsHumansMicrocirculationQuality of LifeTreatment Outcomeacetylcholineadenosineanginacoronary circulationischemiamicrocirculationmicrovascular angina

Identifiers

PMID37259860
PMCPMC10330260
OpenAlexW4378952315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.